Tips for Advising Patients Living in Highly Polluted Settings

Share this content:
Tips for Advising Patients Living in Highly Polluted Settings
Tips for Advising Patients Living in Highly Polluted Settings

TUESDAY, Sept. 18, 2018 (HealthDay News) -- Clinicians advising families living overseas in highly polluted settings should understand their patients' concerns and have a network of resources to draw upon for guidance, according to an article published in the Aug. 1 issue of the Annals of the American Thoracic Society.

Wayne F. Quillin, M.D., from the U.S. Department of State in Washington, D.C., addressed the challenging questions raised by complex environments where patients live, focusing on Americans posted in overseas settings with very high ambient levels of air pollution.

The author notes that clinicians may have patients who are worried about symptoms that might be related to air pollution and/or concerned about the potential long-term risks. Specific tips about communication with patients include taking the time to listen; patients often present with anxieties and knowledge deficits rather than reports of respiratory symptoms, and these need to be addressed. Clinicians should create a network of resources to draw upon. Patients demanding a high level of expertise may be referred to an outside expert or center of excellence. Clinicians should explain that correlations reported are often not causal; reviewing study reports with patients can be helpful.

"Though we may not feel like experts, we are in a far better position than our patients to understand what they are up against in terms of pollution exposure and its potential risks to their health," Quillin writes.

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

WHO: Vaccine Hesitancy a Major Global Health Threat

WHO: Vaccine Hesitancy a Major Global Health Threat

Percentage of U.S. children 19 to 35 months who have not been vaccinated has quadrupled since 2001

FDA Down to 5 Weeks of Funding to Review New Drug Applications

FDA Down to 5 Weeks of Funding to ...

Agency cannot accept new fees or applications until the shutdown is over

FDA Approves First Generic Version of Epilepsy Drug Sabril

FDA Approves First Generic Version of Epilepsy Drug ...

Generic equivalents held to same vigorous manufacturing standards as brand-name drugs

is free, fast, and customized just for you!




Already a member?

Sign In Now »